
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp has demonstrated robust revenue growth, particularly with a 15% increase in its Cardio & Vascular segment in 3Q25, indicating strong demand and market positioning. The company is expected to maintain stable gross margins at 27.0% to 27.3% for 2025 and 2026, alongside projected revenues of $1.87 billion in 2026, reflecting a steady upward trajectory aligned with industry growth forecasts. Additionally, improved operating cash flow, anticipated to reach between $230-$240 million in 2025, positions Integer to reduce leverage ratios effectively, which enhances its financial stability and long-term prospects within a strong cardiovascular device market.
Bears say
Integer Holdings Corp is facing a negative outlook due to a downward adjustment in revenue estimates for 4Q25E, now projected at $460 million, which reflects a modest increase over the prior year but a decrease from earlier estimates of $477 million. Additionally, the company has revised its full-year 2025 revenue guidance downwards, indicating potential challenges in demand for key products and projecting a flat-to-lower growth outlook for 2026E. Management's admission of slow market adoption for critical offerings and the associated expectation of decreasing adjusted operating income further intensifies concerns regarding the company's future performance.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares